Medicare Part B Step Therapy Hyaluronates
Customize your policy alerts
Sign up for zing_health Policy 4664-D alerts
Get alerted when Policy 4664-D changes without checking for updates manually.
Monitor payer policy activity
Coverage of preferred and non-preferred hyaluronate products for Medicare Part B members receiving FDA-approved osteoarthritis treatment; non-preferred products require prior authorization and a qualifying clinical exception.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.